Amylyx Pharmaceuticals Ownership | Who Owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals Ownership Summary
Amylyx Pharmaceuticals is owned by 73.12% institutional investors, 11.41% insiders, and 15.48% retail investors. Perceptive advisors is the largest institutional shareholder, holding 9.95% of AMLX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.16% of its assets in Amylyx Pharmaceuticals shares.
AMLX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Amylyx Pharmaceuticals | 73.12% | 11.41% | 15.48% |
Sector | Healthcare Stocks | 57.00% | 9.26% | 33.74% |
Industry | Biotech Stocks | 68.69% | 8.88% | 22.43% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Perceptive advisors | 6.77M | 9.95% | $25.61M |
Tcg crossover management | 4.64M | 6.82% | $17.55M |
Vanguard group | 2.69M | 3.95% | $10.18M |
Blackrock | 2.67M | 3.93% | $5.07M |
Blackrock funding, inc. /de | 2.28M | 3.35% | $8.61M |
Almitas capital | 2.03M | 2.98% | $7.68M |
683 capital management | 1.93M | 2.83% | $7.30M |
Goldman sachs group | 1.86M | 2.73% | $7.03M |
Abrdn | 1.72M | 2.53% | $6.51M |
Nantahala capital management | 1.45M | 2.13% | $5.49M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Tcg crossover management | 4.64M | 1.72% | $17.55M |
Almitas capital | 2.03M | 1.68% | $7.68M |
Saturn v capital management | 889.07K | 1.32% | $3.36M |
Aldebaran capital | 262.75K | 0.94% | $993.21K |
Perceptive advisors | 6.77M | 0.71% | $25.61M |
683 capital management | 1.93M | 0.45% | $7.30M |
Alpha wave global, lp | 148.63K | 0.26% | $561.81K |
Nantahala capital management | 1.45M | 0.24% | $5.49M |
Ikarian capital | 201.19K | 0.10% | $760.49K |
Point72 asia (singapore) pte. | 72.86K | 0.07% | $275.42K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Perceptive advisors | 6.77M | 0.71% | 4.65M |
Saturn v capital management | 889.07K | 1.32% | 889.07K |
Qube research | 780.57K | 0.00% | 596.67K |
Jacobs levy equity management | 589.11K | 0.00% | 589.11K |
Fmr | 731.36K | 0.00% | 510.36K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Franklin resources | - | - | -1.86M |
Blackrock | 2.67M | 0.00% | -1.80M |
Boxer capital | - | - | -1.50M |
Alyeska investment group | 823.42K | 0.01% | -1.20M |
Acadian asset management | 611.93K | 0.01% | -1.16M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Saturn v capital management | 889.07K | 1.32% | 889.07K | $3.36M |
Jacobs levy equity management | 589.11K | 0.00% | 589.11K | $1.12M |
Orbimed advisors | 348.00K | 0.03% | 348.00K | $1.32M |
Wellington management group llp | 209.71K | 0.00% | 209.71K | $792.70K |
Exoduspoint capital management, lp | 106.24K | 0.00% | 106.24K | $402.00K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -10.00 |
Kelly financial services | -33.00 |
Gamma investing | -35.00 |
Point72 asset management | -200.00 |
Fernwood investment management | -200.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 130 | 12.07% | 49,788,210 | 14.69% | 73 | 1.80% | 65 | 18.18% | 40 | 14.29% |
Sep 30, 2024 | 116 | -8.66% | 43,410,314 | -0.50% | 63 | 1.54% | 56 | -3.45% | 35 | -25.53% |
Jun 30, 2024 | 127 | -28.25% | 43,627,452 | -12.05% | 64 | 1.19% | 58 | -33.33% | 47 | -2.08% |
Mar 31, 2024 | 177 | -14.08% | 49,605,091 | -17.71% | 73 | 0.92% | 87 | -25.64% | 48 | -4.00% |
Dec 31, 2023 | 206 | 8.99% | 60,281,733 | 2.30% | 89 | 1.16% | 117 | 10.38% | 50 | 2.04% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.48M | 2.16% | - |
abrdn Healthcare Investors | 1.20M | 1.74% | -17.82K |
Vanguard Institutional Extnd Mkt Idx Tr | 727.34K | 1.06% | - |
Vanguard Small Cap Index | 646.02K | 0.95% | 1.52K |
Fidelity Select Biotechnology | 782.81K | 0.91% | - |
abrdn Life Sciences Investors | 527.22K | 0.77% | -7.85K |
Jupiter Merian Glb Eq AbsRet I USD Acc | 480.21K | 0.71% | 185.87K |
Vanguard Small Cap Growth Index Inv | 357.96K | 0.53% | -1.58K |
Schwab Small-Cap Equity | 331.23K | 0.49% | 240.56K |
iShares Biotechnology ETF | 342.44K | 0.40% | 67.53K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 03, 2025 | Mazzariello Gina | Chief Legal Officer | Sell | $12.84K |
Feb 03, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | $41.11K |
Feb 03, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | $41.10K |
Jan 06, 2025 | Klee Justin B. | Co-Chief Executive Officer | Sell | $30.20K |
Jan 06, 2025 | Cohen Joshua B | Co-Chief Executive Officer | Sell | $30.23K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 5 |
2024 Q4 | - | 1 |
2024 Q3 | 3 | 4 |
2024 Q2 | 2 | 1 |
2024 Q1 | - | 9 |
AMLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools